CD163 and type 2 diabetes mellitus: Our findings of aberrant PAC differentiation are in line with previous studies that showed diminished proliferative capacity by T2DM PAC as well as a reduced frequency of circulating pro-angiogenic monocytes expressing CD14 or CD163 (18, 19).